Engage Therapeutics, Inc. clinical trials

Acquired by UCB S.A., 2020 · source ↗

The registry lists 2 studies whose lead sponsor is Engage Therapeutics, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 7, 2022.

Before and after it joined UCB S.A.

First submitted before Engage Therapeutics, Inc. became part of UCB S.A.: 2
First submitted after Engage Therapeutics, Inc. became part of UCB S.A.: 0
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Completed: 2

Phase

Phase 1: 1
Phase 2: 1

Where

United States: 2
Jamaica: 1
Australia: 1

Registry sponsor names on this page

Engage Therapeutics, Inc.2 studies

Something wrong with this grouping? Tell us on the UCB S.A. page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All UCB S.A. studies →

Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-SmokersCompletedNCT03516305Phase 1
Sponsor listed in the registry: Engage Therapeutics, Inc. · First submitted before Engage Therapeutics, Inc. became part of UCB S.A.
Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure PatternCompletedNCT03478982Phase 2
Sponsor listed in the registry: Engage Therapeutics, Inc. · First submitted before Engage Therapeutics, Inc. became part of UCB S.A.